Menu

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture

New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications

Jun 26, 2019
Thermo Fisher Scientific

As the pharmaceutical industry continues to increase its focus on the development of biologics, scientists require robust, automation-ready incubation solutions with the reliability and flexibility to support a range of discovery, development and processing applications for future cell-based and cell-derived medicines.

Underpinned by over 50 years of experience in advanced environmental chamber and incubation technology, the Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator provides research scientists and cell culture biologists in the pharmaceutical industry with an automation-ready, mid-capacity cell culture solution. The new automated incubator system delivers cell growth and environmental control across a range of microplate applications, including cell-based screening, immuno-capture assays, microbiology and enzyme testing. Designed for fast and flexible integration, the Cytomat 2 C-LiN Series Automated Incubator enhances laboratory automation installations.

Thermo Fisher Scientific is showcasing its new generation of automated incubators during the 2019 European conference and exhibition of the Society for Laboratory Automation and Screening (SLAS Europe) being held June 26–28, Booth #418 at the Centre de Convencions Internacional, Barcelona, Spain.

"With the increasing number of biotherapeutics in development and their ever-growing complexity, scientists need cell culture solutions they can trust to deliver dependable cellular growth within a controlled and contamination-free environment," said Hansjoerg Haas, senior director and general manager, laboratory automation, Thermo Fisher Scientific. "The launch of the Cytomat 2 C-LiN Series Automated Incubator brings the latest automation-ready incubation technology to mid-capacity microplate applications, enabling scientists to more easily sustain valuable and vital cell lines for the synthesis and development of future therapeutics."

The Cytomat 2 C-LiN Series Automated Incubator provides research scientists and cell culture biologists with: 

  • Controlled humidity through the optional Hydra Smart ultrasonic vaporizer and easy-to-fill external water tank, which removes the need to open the system to maintain water stocks, protecting cells from fluctuating environmental conditions.
  • Reduced risk of contamination through an optional solid copper chamber, as well as a built-in ContraCon automatic decontamination routine, which employs a combination of heat and high humidity.
  • Flexible integration possibilities for quick and easy configuration into laboratory automation platforms via multiple gate positions.
  • A new, quick plate shuttle system design with a mean access time of 12 seconds.
  • A versatile cell culture solution that supports the growth and maintenance of stem, primary, immortalized and organoid cell lines.


October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Marketplace

Sponsored Product Updates

Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
·        Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting· The MODA-ES™ Platform was implemented at Nephron in an aggressive nine-month time frame, improving operational efficiency and enabling a significant product line expansion·        Full results of the collaboration will be co-presented by Lonza and Nephron at the 2019 ISPE Annual Meeting & Expo in Las Vegas, Nevada
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogenic CAR-T cells.
Zymo Research launches new RNA-Seq library prep kit
Zymo Research launches new RNA-Seq library prep kit
Zymo Research is excited to announce the fastest and easiest total RNA-Seq library prep kit that allows users to go from sample to sequencer in a single day!